Checkpoint Therapeutics, Inc.
CKPT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -60.2% | -46.4% | -28.4% | – |
| Gross Profit | $0 | -$0 | -$0 | -$0 |
| % Margin | 100% | -42,197.1% | -25,850.5% | -17,979.5% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -137,009.8% | -50,629.1% | -28,063.5% | -21,077% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -137,170.7% | -50,336.9% | -32,616.7% | -21,125.7% |
| EPS Diluted | -1.42 | -2.77 | -7.09 | -7.45 |
| % Growth | 48.7% | 60.9% | 4.8% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |